Preventing and treating hepatitis B infection

被引:38
作者
Aggarwal, R [1 ]
Ranjan, P [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India
来源
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7474期
关键词
D O I
10.1136/bmj.329.7474.1080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis B virus infection is a global public health problem. Hepatitis B vaccines are highly effective, long acting, and safe, making prevention and even eventual eradication possible. However, treatment options for patients who are already infected are limited. The currently available drugs are effective only in selected subsets of patients and have low efficacy rates, and their long term impact on occurrence of complications remains unknown.
引用
收藏
页码:1080 / 1086
页数:7
相关论文
共 34 条
  • [1] Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model
    Aggarwal, R
    Ghoshal, UC
    Naik, SR
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 (02) : 215 - 222
  • [2] Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6
  • [3] Antiretroviral therapy and HIV/hepatitis B virus coinfection
    Benhamou, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 : S98 - S103
  • [4] Seroepidemiology of hepatitis B virus infection in children - Ten years of mass vaccination in Taiwan
    Chen, HL
    Chang, MH
    Ni, YH
    Hsu, HY
    Lee, PI
    Lee, CY
    Chen, DS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11): : 906 - 908
  • [5] Peginterferon α-2a (40 kDa):: an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B
    Cooksley, WGE
    Piratvisuth, T
    Lee, SD
    Mahachai, V
    Chao, YC
    Tanwandee, T
    Chutaputti, A
    Chang, WY
    Zahm, FE
    Pluck, N
    [J]. JOURNAL OF VIRAL HEPATITIS, 2003, 10 (04) : 298 - 305
  • [6] Lamivudine as initial treatment for chronic hepatitis B in the United States
    Dienstag, JL
    Schiff, ER
    Wright, TL
    Perrillo, RP
    Hann, HWL
    Goodman, Z
    Crowther, L
    Condreay, LD
    Woessner, M
    Rubin, M
    Brown, NA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) : 1256 - 1263
  • [7] *EASL JUR, 2003, J HEPATOL, V38, P533
  • [8] Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
    Ganem, D
    Prince, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) : 1118 - 1129
  • [9] Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B
    Hadziyannis, SJ
    Papatheodoridis, GV
    Dimou, E
    Laras, A
    Papaioannou, C
    [J]. HEPATOLOGY, 2000, 32 (04) : 847 - 851
  • [10] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Wulfsohn, MS
    Xiong, S
    Fry, J
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) : 800 - 807